RxDoctor Payments Data

Laura Lienemann

Family · Marlton, NJNPI 1538526538

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $773, 4.5 times the $172 reported in 2022.

$1,854in general payments, 2019–2025

Across 114 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$317
  • CSL Behring$313
  • Takeda Pharmaceuticals U.S.A., Inc.$282
  • Sanofi$218
  • ARS Pharmaceuticals Operations, Inc.$147
  • Regeneron Healthcare Solutions, Inc.$132
  • plus $446 from 15 others

What the payments were for

  • Food & beverage$1,79897%
  • Education$563%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,854 in reported general payments places this provider in the 85th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey →

Other family in Marlton

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →